<unk>  is indicated for reduction of renal radiation exposure during peptide receptor radionuclide therapy (PRRT) with lutetium (177Lu) oxodotreotide in adults.
Arginine/lysine
Phosphine
Inositol
Gluten
Saline 
Glycoside
Glycogen
Choline